Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties Track

Application of 18F-NaF PET/CT imaging in prognosis of fractures and treatment planning in patients with fibrous dysplasia.

Georgios Papadakis, Georgios Manikis, Apostolos Karantanas, Kostas Marias, Michael Collins and Alison Boyce
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 308;
Georgios Papadakis
2National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR) Bethesda MD United States
1Foundation for Research and Technology (FORTH), Institute of Computer Science (ICS) Heraklion Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georgios Manikis
1Foundation for Research and Technology (FORTH), Institute of Computer Science (ICS) Heraklion Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Apostolos Karantanas
1Foundation for Research and Technology (FORTH), Institute of Computer Science (ICS) Heraklion Greece
3Radiology University of Crete, School of Medicine Heraklion Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kostas Marias
1Foundation for Research and Technology (FORTH), Institute of Computer Science (ICS) Heraklion Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Collins
2National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR) Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison Boyce
2National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR) Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

308

Objectives: Fibrous dysplasia (FD) is an uncommon, benign skeletal disorder characterized by replacement of normal bone and normal bone marrow with abnormal fibro-osseous tissue, leading to bone deformity, fractures and significant physical impairment. FD may affect one or multiple bones and may occur in isolation or in combination with extra-skeletal manifestations termed McCune-Albright syndrome (MAS) (hyperfunctioning endocrinopathies, skin pigmentation) and Mazabraud's syndrome (intramuscular myxomas). 18F-NaF is a bone-seeking PET-agent with favorable pharmacokinetics, which can effectively target the underlying bone processes encountered in FD. Aim of the current study was to investigate potential application of 18F-NaF PET/CT imaging in prognosis of fractures and treatment planning in FD patients.

Methods: Sixteen FD patients were evaluated with whole-body 18F-NaF PET/CT scans. PET images from the vertex of the skull to the plantar surface of the feet were acquired on dedicated PET/CT scanners, 58 to 70 minutes after i.v. injection of 2.72-3.26 mCi of 18F-NaF. A non-contrast, low dose, non-diagnostic CT scan was performed for attenuation correction and co-registration purposes. FD burden was assessed by quantifying 18F-NaF activity corresponding to FD lesions using the MIM Vista workstation (version 6.5.9). A volume of interest (VOI) encompassing the entire skeleton was drawn, and subsequently a SUVmax threshold based approach customized per patient was applied in order to include all FD-related bone uptake. Separate VOIs encircling all areas above the SUVmax threshold set by the user were automatically generated and areas with physiologic or not related to the disease 18F-NaF activity were manually excluded by a nuclear medicine physician. Finally, the following parameters were automatically obtained: SUVmax, SUVmean (average SUV) and whole skeleton disease indices of total volume (TV) of all 18F-NaF avid FD lesions and total lesions activity (TA), which is determined as the summation of the activity of each individual FD lesion which is the product of each individual lesion volume multiplied by its' mean SUV respectively. Subsequently, spearman’s rank correlation test was applied to investigate potential associations between the parameters obtained from the 18F-NaF PET/CT scans for the skull and the whole-body with the number of fractures (lifetime, mean fractures per year) and the performed surgeries (craniofacial, orthopedic).

Results: TV and TA of FD lesions in the skull were very strongly associated (Spearman’s rho=0.8314, p<0.01 & rho=0.8548, p<0.01) with lifetime craniofacial surgeries, and with mean craniofacial surgeries per year (rho=0.8348, p<0.01 & rho=0.86, p<0.01) (table 1). In addition, total volume and total activity of whole-body FD lesions very strongly correlated with the lifetime fractures (rho=0.8729, p<0.01 & rho=0.8296, p<0.01) and mean fractures per year (rho=0.8721, p<0.01 & rho=0.8108, p<0.01) (table 2). Also very strong associations were found between total volume and total activity of whole-body FD lesions and lifetime orthopedic surgeries (rho=0.8803, p<0.01 & rho=0.9055, p<0.01) and mean orthopedic surgeries per year (rho=0.8774, p<0.01 & rho=0.8948, p<0.01) (table 2). Neither SUVmax nor SUVmean of FD lesions either in the skull or the torso showed any statistical significant association with fractures or surgeries in skull and body respectively.

Conclusion: Total volume and total activity of 18F-NaF avid bone lesions is of prognostic value for determination of fractures and surgeries in patients diagnosed with FD of the bone. The presented data indicate application of 18F-NaF PET/CT imaging in stratifying FD patients with higher likelihood of bone fractures and need of surgical interventions. Research Support: This project was supported by the National Institute of Dental & Craniofacial Research (NIDCR), Bethesda, MD, USA

View this table:
  • View inline
  • View popup

Spearman’s (rho) between TA, TV of FD lesions in the skull and craniofacial surgeries.

View this table:
  • View inline
  • View popup

Spearman’s (rho) between TA, TV of whole-body FD lesions and fractures, surgeries.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Application of 18F-NaF PET/CT imaging in prognosis of fractures and treatment planning in patients with fibrous dysplasia.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Application of 18F-NaF PET/CT imaging in prognosis of fractures and treatment planning in patients with fibrous dysplasia.
Georgios Papadakis, Georgios Manikis, Apostolos Karantanas, Kostas Marias, Michael Collins, Alison Boyce
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 308;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Application of 18F-NaF PET/CT imaging in prognosis of fractures and treatment planning in patients with fibrous dysplasia.
Georgios Papadakis, Georgios Manikis, Apostolos Karantanas, Kostas Marias, Michael Collins, Alison Boyce
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 308;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties Track

  • Quantitative Evaluation of Parathyroid Adenoma and Hyperplasia in Reference to Thyroid using Tc-99m MIBI SPECT/CT
  • A primitive study for clinical application of 18F-AlF-NOTA-octreotide PET/CT in combination with 18F-FDG PET/CT for imaging neuroendocrine neoplasms
  • Role of 18F-FDG PET/CT in detection of disease burden and response assessment in patients with myeloid sarcoma
Show more General Clinical Specialties Track

Musculoskeletal

  • Ultra-low-dose total-body 18F-FDG PET/CT in patients with autoimmune inflammatory arthritis: evaluation of image quality with shorter scan time
  • SPECT/CT imaging characteristics and clinical analysis of 81 cases of super scan
  • Diagnostic performance of quantitative bone SPECT/CT in patients with suspected osteomyelitis of the jaw
Show more Musculoskeletal

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire